Aikeremujiang Muheremu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aikeremujiang Muheremu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Abudunaibi Aili
Department of Spine Surgery, Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 86830001, China
1 shared publication- Aikeremujiang Muheremu
Key Laboratory of Orthopedic Regenerative Medicine, Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, China
1 shared publication Chen Chaohui
Orthopedic Department, Union Hospital, Fujian Medical University, No 1, Xueyuan Road, Campus Town, Fuzhou, Fujian, China
1 shared publicationHexige Saiyin
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200433, China
1 shared publication- Lihuan Cao
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200433, China
1 shared publication Liu Wenge
1 shared publication
Latest Publications
- 1 December 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1128)
PET–CT for the diagnosis and treatment of primary musculoskeletal tumors in Chinese patients - experience from 255 patients in a single center
Objective: The current study was carried out to assess the value of positron emission tomography (PET)/CT on the diagnosis and staging of primary musculoskeletal tumors.Methods: PET–CT test results and histopathological study reports of all the patients with primary musculoskeletal tumors in our department from January 2006 to July 2015 were retrospectively reviewed. Maximum standardized uptake value (SUVmax) in these PET–CT reports were recorded and analyzed respectively for each type of sarcoma.Results: A total of 255 patients were included in the final analysis. Sensitivity of SUVmax based diagnosis was 96.6% for primary malignant osseous sarcomas and 91.2% for soft tissue sarcomas. SUVmax of high-grade osseous sarcomas (average 8.4 ± 5.5) was significantly higher (p < 0.001) than low-grade osseous sarcomas (average 3.9 ± 1.8); based on current case series, SUVmax of high-grade soft tissue sarcomas (7.5 ± 5.1) was not significantly different (p = 0.229) from that of low-grade soft tissue sarcomas (5.3 ± 3.7). Significant decrease of SUVmax value after chemotherapy was associated with favorable prognosis in patients with osteosarcoma.Conclusion: Results of the current study indicate that, the SUVmax based application of PET–CT can be a valuable supplementary method to histopathological tests regarding the diagnosis and staging of primary musculoskeletal sarcomas.Advances in knowledge: SUVmax based application of PET–CT is a highly sensitive method in diagnosis of primary osseous and soft tissue sarcomas in Chinese patients.
- 1 December 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1128)
PET–CT for the diagnosis and treatment of primary musculoskeletal tumors in Chinese patients - experience from 255 patients in a single center
Objective: The current study was carried out to assess the value of positron emission tomography (PET)/CT on the diagnosis and staging of primary musculoskeletal tumors.Methods: PET–CT test results and histopathological study reports of all the patients with primary musculoskeletal tumors in our department from January 2006 to July 2015 were retrospectively reviewed. Maximum standardized uptake value (SUVmax) in these PET–CT reports were recorded and analyzed respectively for each type of sarcoma.Results: A total of 255 patients were included in the final analysis. Sensitivity of SUVmax based diagnosis was 96.6% for primary malignant osseous sarcomas and 91.2% for soft tissue sarcomas. SUVmax of high-grade osseous sarcomas (average 8.4 ± 5.5) was significantly higher (p < 0.001) than low-grade osseous sarcomas (average 3.9 ± 1.8); based on current case series, SUVmax of high-grade soft tissue sarcomas (7.5 ± 5.1) was not significantly different (p = 0.229) from that of low-grade soft tissue sarcomas (5.3 ± 3.7). Significant decrease of SUVmax value after chemotherapy was associated with favorable prognosis in patients with osteosarcoma.Conclusion: Results of the current study indicate that, the SUVmax based application of PET–CT can be a valuable supplementary method to histopathological tests regarding the diagnosis and staging of primary musculoskeletal sarcomas.Advances in knowledge: SUVmax based application of PET–CT is a highly sensitive method in diagnosis of primary osseous and soft tissue sarcomas in Chinese patients.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 6231697
The Correct Localization of Borealin in Midbody during Cytokinesis Depends on IQGAP1
Borealin is a key component of chromosomal passenger complex, which is vital in cytokinesis. IQ domain‐containing GTPase‐activating protein 1 (IQGAP1) also participates in cytokinesis. The correlation between Borealin and IQGAP1 during cytokinesis is not yet clear. Here, we used mass spectrometry and endogenous coimmunoprecipitation experiments to investigate the interaction between IQGAP1 and Borealin. Results of the current study showed that Borealin interacted directly with IQGAP1 both in vitro and in vivo. Knockdown of IQGAP1 resulted in an abnormal location of Borealin in the midbody. Knocking down Borealin alone, IQGAP1 alone, or Borealin and IQGAP1 at the same time inhibited the completion of cytokinesis and formed multinucleated cells. Our results indicated that IQGAP1 interacts with Borealin during cytokinesis, and the correct localization of Borealin in the midbody during cytokinesis is determined by IQGAP1, and IQGAP1 may play an important role in regulating Borealin function in cytokinesis.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 6231697
Open AccessThe Correct Localization of Borealin in Midbody during Cytokinesis Depends on IQGAP1
Borealin is a key component of chromosomal passenger complex, which is vital in cytokinesis. IQ domain‐containing GTPase‐activating protein 1 (IQGAP1) also participates in cytokinesis. The correlation between Borealin and IQGAP1 during cytokinesis is not yet clear. Here, we used mass spectrometry and endogenous coimmunoprecipitation experiments to investigate the interaction between IQGAP1 and Borealin. Results of the current study showed that Borealin interacted directly with IQGAP1 both in vitro and in vivo. Knockdown of IQGAP1 resulted in an abnormal location of Borealin in the midbody. Knocking down Borealin alone, IQGAP1 alone, or Borealin and IQGAP1 at the same time inhibited the completion of cytokinesis and formed multinucleated cells. Our results indicated that IQGAP1 interacts with Borealin during cytokinesis, and the correct localization of Borealin in the midbody during cytokinesis is determined by IQGAP1, and IQGAP1 may play an important role in regulating Borealin function in cytokinesis.
- Open Access
- 20 August 2014
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 12 (1) , 1-9
Pulmonary metastasis of giant cell tumor of bones
Giant cell tumor of bone (GCTB) accounts for 5% of primary skeletal tumors. Although it is considered to be a benign lesion, there are still incidences of pulmonary metastasis. Pulmonary metastasis of GCTB may be affected by tumor grading and localization as well as the age, gender and overall health status of the patient. Patients with local recurrence are more likely to develop pulmonary metastasis of GCTB. High expression of some genes, cytokines and chemokines may also be closely related to the metastatic potential and prognosis of GCTB. The treatment of the primary GCTB is key to the final outcome of the disease, as intralesional curettage has a significantly higher local recurrence and pulmonary metastasis rate than wide resection. However, even patients with pulmonary metastasis seem to have a good prognosis after timely and appropriate surgical resection. It is hoped that with the development of novel surgical methods and drugs, pulmonary metastasis of GCTB can be prevented and treated more effectively.
- 20 August 2014
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 12 (1) , 1-9
Open AccessPulmonary metastasis of giant cell tumor of bones
Giant cell tumor of bone (GCTB) accounts for 5% of primary skeletal tumors. Although it is considered to be a benign lesion, there are still incidences of pulmonary metastasis. Pulmonary metastasis of GCTB may be affected by tumor grading and localization as well as the age, gender and overall health status of the patient. Patients with local recurrence are more likely to develop pulmonary metastasis of GCTB. High expression of some genes, cytokines and chemokines may also be closely related to the metastatic potential and prognosis of GCTB. The treatment of the primary GCTB is key to the final outcome of the disease, as intralesional curettage has a significantly higher local recurrence and pulmonary metastasis rate than wide resection. However, even patients with pulmonary metastasis seem to have a good prognosis after timely and appropriate surgical resection. It is hoped that with the development of novel surgical methods and drugs, pulmonary metastasis of GCTB can be prevented and treated more effectively.
- 1 March 2013
- Published by Taylor & Francis in Journal of Musculoskeletal Pain
- Vol. 21 (1) , 37-45
Effectiveness of Tai Chi Practice for Non-Specific Chronic Low Back Pain on Retired Athletes: A Randomized Controlled Study
ObjectiveTo determine whether tai chi practice is superior to other means of sports rehabilitation to relieve non-specific chronic low back pain [LBP] in a younger population.MethodsWe randomized 320 retired athletes [aged 37.6 ± 5.4 years, 60.0 percent men] with chronic LBP [visual analog scale ≥40 mm] into treatment [tai chi practice] and control groups. At the beginning, middle, and end of a six-month intervention, patients from both treatment and control groups completed questionnaires assessing the intensity of LBP, and a systematic physical examination was arranged to evaluate participants' health condition. The results were analyzed by one way analysis of variance using statistical software SPSS 17.0. Differences were considered significant if P < 0.05.ResultsAfter three and six months, no statistically significant difference in the intensity of LBP was demonstrated between the tai chi and swimming groups; significant differences were demonstrated among the tai chi and backward walking, jogging,...
- 1 March 2013
- Published by Taylor & Francis in Journal of Musculoskeletal Pain
- Vol. 21 (1) , 37-45
Effectiveness of Tai Chi Practice for Non-Specific Chronic Low Back Pain on Retired Athletes: A Randomized Controlled Study
ObjectiveTo determine whether tai chi practice is superior to other means of sports rehabilitation to relieve non-specific chronic low back pain [LBP] in a younger population.MethodsWe randomized 320 retired athletes [aged 37.6 ± 5.4 years, 60.0 percent men] with chronic LBP [visual analog scale ≥40 mm] into treatment [tai chi practice] and control groups. At the beginning, middle, and end of a six-month intervention, patients from both treatment and control groups completed questionnaires assessing the intensity of LBP, and a systematic physical examination was arranged to evaluate participants' health condition. The results were analyzed by one way analysis of variance using statistical software SPSS 17.0. Differences were considered significant if P < 0.05.ResultsAfter three and six months, no statistically significant difference in the intensity of LBP was demonstrated between the tai chi and swimming groups; significant differences were demonstrated among the tai chi and backward walking, jogging,...